既往含大流行H1N1流感疫苗接种与自然流产及出生缺陷风险
结果显示自然流产风险比约为1.0,出生缺陷无关联,为孕期重复接种含pH1N1疫苗的安全性提供支持证据。
要点
- 既往接种含pH1N1流感疫苗与自然流产风险无显著关联(aHR约1.0)。
- 接种后28天内自然流产风险略升高但置信区间不精确(aHR 1.19)。
- 未观察到含pH1N1疫苗接种与出生缺陷的关联。
核心结论
- 本研究为孕期接种含pH1N1流感疫苗提供了额外安全性证据,支持无论前一季节接种何种疫苗均可接种。
研究设计与样本
- 采用Cox回归和改良Poisson回归分别估计前一流感季节接种含pH1N1疫苗与自然流产及出生缺陷的关联。
主要发现
- 26,264例妊娠中,21,736例(82.8%)在前一流感季节接种含pH1N1疫苗,4,528例(17.2%)接种非含pH1N1疫苗。
- 23,121名婴儿中,19,365名(83.8%)母亲前一季节接种含pH1N1疫苗,3,756名(16.2%)未接种。
- 全程随访自然流产调整风险比近似1.0(95%CI:0.89-1.13)。
- 接种后28天截尾时自然流产调整风险比略升高但置信区间不精确(aHR:1.19;95%CI:0.97-1.46)。
- 未观察到含pH1N1疫苗接种与出生缺陷的关联。
临床怎么用
- 孕期接种含pH1N1流感疫苗未显示增加自然流产或出生缺陷风险,可支持孕期流感疫苗接种。
- 对既往流感季节已接种含pH1N1疫苗者,再次接种的安全性证据有限但不提示风险增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: One recent study suggested an association between receipt of pandemic H1N1 (pH1N1)-containing vaccines in consecutive influenza seasons and spontaneous abortion, but corroborating scientific evidence is limited. In the present study, we leveraged a population of vaccine-compliant pregnant military women to examine history of pH1N1-containing influenza vaccination and adverse pregnancy outcomes. Because seasonal influenza vaccination is compulsory for military service, safety concerns regarding repeat vaccination are particularly relevant in this population. METHODS: Pregnancies and live births from Department of Defense Birth and Infant Health Research program data were linked with military personnel immunization records to identify women vaccinated with a pH1N1-containing vaccine in pregnancy prior to 21 6/7 weeks' gestation, October 2009-April 2015. Cox and modified Poisson regression models estimated associations between vaccination with pH1N1- versus non-pH1N1-containing influenza vaccine in the season prior to the index pregnancy, and spontaneous abortion and birth defects, respectively. Cox models were calculated for two periods of follow-up: through (1) 21 6/7 weeks' gestation and (2) 28 days postvaccination. RESULTS: Of 26,264 pregnancies, 21,736 (82.8%) were among women who received a dose of pH1N1-containing vaccine in the prior influenza season and 4,528 (17.2%) were among women who received non-pH1N1-containing vaccine in the prior influenza season. Among 23,121 infants, 19,365 (83.8%) and 3,756 (16.2%) had mothers exposed and unexposed to pH1N1-containing vaccine in the prior influenza season, respectively. The adjusted hazard ratio (aHR) for spontaneous abortion approximated 1.0 across the complete follow-up period (95% confidence interval [CI]: 0.89-1.13) and was slightly elevated when censored at 28 days postvaccination, though the CI was imprecise (aHR: 1.19; 95% CI: 0.97-1.46). No associations with birth defects were observed. CONCLUSION: This work lends additional safety evidence and support for vaccination against pH1N1 in pregnancy, regardless of the vaccine received in the prior influenza season.
引用
- Romano CJ, Hall C, Khodr ZG, et al. History of pandemic H1N1-containing influenza vaccination and risk for spontaneous abortion and birth defects. Vaccine. 2021. PMID: 34598819. doi:10.1016/j.vaccine.2021.09.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。